Alfred D. Kingsley

Insider Reports History

Entity
Individual
Location
150 E 57 Th Street, New York, NY
Signature
/s/ Alexandra Hernandez, as Attorney-in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alfred D. Kingsley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncocyte Corp Director Common Stock, no par value 489K $105K $0.21 Jun 23, 2023 Direct
Oncocyte Corp Director Common Stock, no par value 18.8K $4.03K $0.21 Jun 23, 2023 Indirect
Oncocyte Corp Director Option to Purchase Common Stock 90K Jun 23, 2023 Direct
Lineage Cell Therapeutics, Inc. Chairman, Director Stock Option (Right to Buy) 50K Jul 1, 2023 Direct

Insider Reports Filed by Alfred D. Kingsley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 3, 2023 Chairman, Director
OCX Oncocyte Corp Jun 23, 2023 2 $0 4 Jun 27, 2023 Director
OCX Oncocyte Corp Jun 14, 2023 1 $6.45K 4 Jun 15, 2023 Director
LCTX Lineage Cell Therapeutics, Inc. Dec 31, 2022 1 $0 5 Feb 14, 2023 Director
OCX Oncocyte Corp Dec 22, 2022 1 $7.13K 4 Dec 27, 2022 Director
OCX Oncocyte Corp Aug 15, 2022 4 $9.7K 4 Aug 17, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
OCX Oncocyte Corp Jun 24, 2022 2 $0 4 Jul 19, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Dec 31, 2021 1 $0 5 Feb 11, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2021 1 $0 4 Jul 1, 2021 Director
OCX OncoCyte Corp Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
LCTX Lineage Cell Therapeutics, Inc. Jun 22, 2021 2 $136K 4 Jun 23, 2021 Director